INVO Bioscience INVO Stock
1.27 USD
{{ price }}
-7.299272%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Medical Devices
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
2.13M USD
LOW - HIGH [24H]
0.78
-
0.94 USD
VOLUME [24H]
650.14K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-10.34 USD
INVO Bioscience Price Chart
INVO Bioscience INVO Financial and Trading Overview
| INVO Bioscience stock price | 1.27 USD |
| Previous Close | 0.17 USD |
| Open | 0.17 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1100 |
| Day's Range | 0.16 - 0.17 USD |
| 52 Week Range | 0.15 - 1.65 USD |
| Volume | 634.36K USD |
| Avg. Volume | 452.37K USD |
| Market Cap | 2.37M USD |
| Beta (5Y Monthly) | 1.224647 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.34 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
INVO Valuation Measures
| Enterprise Value | 3.13M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.8495 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.355765 |
| Price/Book (mrq) | 28.316666 |
| Enterprise Value/Revenue | 3.109 |
| Enterprise Value/EBITDA | -0.309 |
Trading Information
INVO Bioscience Stock Price History
| Beta (5Y Monthly) | 1.224647 |
| 52-Week Change | -80.70% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.65 USD |
| 52 Week Low | 0.15 USD |
| 50-Day Moving Average | 0.35 USD |
| 200-Day Moving Average | 0.72 USD |
INVO Share Statistics
| Avg. Volume (3 month) | 452.37K USD |
| Avg. Daily Volume (10-Days) | 1.65M USD |
| Shares Outstanding | 13.97M |
| Float | 11.36M |
| Short Ratio | 1.07 |
| % Held by Insiders | 8.89% |
| % Held by Institutions | 9.49% |
| Shares Short | 52.66K |
| Short % of Float | 0.38% |
| Short % of Shares Outstanding | 0.38% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1015.45% |
| Gross Margin | 71.15% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -87.17% |
| Return on Equity (ttm) | -375.76% |
Income Statement
| Revenue (ttm) | 1.01M USD |
| Revenue Per Share (ttm) | 0.08 USD |
| Quarterly Revenue Growth (yoy) | 113.99% |
| Gross Profit (ttm) | 535.27K USD |
| EBITDA | -10151122 USD |
| Net Income Avi to Common (ttm) | -10669078 USD |
| Diluted EPS (ttm) | -0.77 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.19M USD |
| Total Cash Per Share (mrq) | 0.16 USD |
| Total Debt (mrq) | 2.95M USD |
| Total Debt/Equity (mrq) | 3330.21 USD |
| Current Ratio (mrq) | 0.631 |
| Book Value Per Share (mrq) | 0.006 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5673661 USD |
| Levered Free Cash Flow (ttm) | -1643186 USD |
Profile of INVO Bioscience
| Country | United States |
| State | FL |
| City | Sarasota |
| Address | 5582 Broadcast Court |
| ZIP | 34240 |
| Phone | 978 878 9505 |
| Website | https://www.invobio.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 15 |
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.
Q&A For INVO Bioscience Stock
What is a current INVO stock price?
INVO Bioscience INVO stock price today per share is 1.27 USD.
How to purchase INVO Bioscience stock?
You can buy INVO shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for INVO Bioscience?
The stock symbol or ticker of INVO Bioscience is INVO.
Which industry does the INVO Bioscience company belong to?
The INVO Bioscience industry is Medical Devices.
How many shares does INVO Bioscience have in circulation?
The max supply of INVO Bioscience shares is 1.68M.
What is INVO Bioscience Price to Earnings Ratio (PE Ratio)?
INVO Bioscience PE Ratio is now.
What was INVO Bioscience earnings per share over the trailing 12 months (TTM)?
INVO Bioscience EPS is -10.34 USD over the trailing 12 months.
Which sector does the INVO Bioscience company belong to?
The INVO Bioscience sector is Healthcare.
INVO Bioscience INVO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}